NRG and Mallinckrodt Comment on the Status of the HFR

June 5, 2013

NRG and Mallinckrodt Comment on the Status of the HFR

NRG, the operator of the High Flux Reactor (HFR), recently provided an update concerning the necessary repairs that are currently affecting the reactor. While they continue to make progress, they anticipate that the reactor will not return to service before the middle of May.  As a result, customers should make the operational assumption that the HFR will remain out of service until further notice.  Additionally, Mallinckrodt, the Pharmaceutical business of Covidien, has provided a calendar detailing the current projections of isotope availability in May. For more information, please find the NRG and Mallinckrodt letters below.

NRG Letter - 4-16

Mallinckrodt Letter - 4-16